Skip to content
akaturk Academic measurement
Sign in Register

Academician

ALİ RİZA UMUT ŞAHİN

DOÇENT

SABANCI ÜNİVERSİTESİ MÜHENDİSLİK VE DOĞA BİLİMLERİ FAKÜLTESİ MOLEKÜLER BİYOLOJİ, GENETİK VE BİYOMÜHENDİSLİK BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Moleküler Biyoloji ve Genetik
Articles 17 YÖKSİS · 17 OpenAlex · 0
Projects 0
Books 3
Proceedings 25

Article counts come from two sources, each shown separately: YÖKSİS (academic declarations) and OpenAlex (open scholarly catalog). Patents and artistic activities are listed under the Works tabs below.

Index quartiles

Scopus (SJR)

14 Total

  • Q1 14
  • Q2 0
  • Q3 0
  • Q4 0
Other counts
  • YÖKSİS rows 15 Q1 0 Q2 0 Q3 0 Q4 0

WoS (JCR)

14 Total

  • Q1 9
  • Q2 4
  • Q3 1
  • Q4 0
Other counts
  • YÖKSİS rows 15 Q1 0 Q2 0 Q3 0 Q4 0

TR Index

0 articles

OpenAlex citation percentiles

Top 1% articles 0
Top 10% articles 6
Avg percentile 86.4%
Articles with percentile 15

OpenAlex citation percentile; covered works only (~52%).

What do these indicators mean?
  • Q1–Q4: the quartile of the journal in the given index (Scopus/WoS). Q1 = top 25%, Q4 = bottom 25%.
  • Top 1% / top 10%: number of works among the top 1% or 10% most-cited worldwide in the same field and year.
  • Avg percentile: mean citation percentile of the works (100 = highest).
  • Source: index quartiles from Scopus/WoS and TR Index flags; citation percentiles from OpenAlex.

Proceedings

Conference proceedings recorded in YÖKSİS.

Records

Showing 20 / 25

  1. 2023 A SUMO-modulating targeted therapy for the treatment of NEK1-driven amyotrophic lateral sclerosis EMBO SUMO Workshop
  2. 2015 In vivo proteomic analysis of sumoylation under oxidative stress EMBO conference on ubiquitin and ubiquitin like modifiers, Cavtat, Croatia
  3. 2010 Sumoylation of Human Ago2 Regulates its Stability RUBICON (Role of ubiquitin and ubiquitin-like modifiers in cellular regulation), 4th Planery Meeting
  4. 2018 CRISPR-asccociated protein Cas9 is modified by SUMOylation 18th EMBO (European Molecular Biology Organization) Young Investigator Meeting
  5. 2014 PML nuclear body enhanced SUMOylation clears HTLV1 Tax upon arsenic interferon combination therapy 7th International Conference on SUMO, Ubiquitin and Ubiquitin-like Proteins, Implications for Human Disease.
  6. 2013 Interferons regulate SUMO availability through a microRNA based mechanism 4th International EMBO Conference on Ubiquitin and Ubiquitin-like Proteins
  7. 2015 Tax as a therapeutic target in ATL 17th International Conference on Human Retroviruses
  8. 2017 Destruction of Toxic Proteins Via PML/SUMO-dependent Proteolysis 5th International BAU Drug Design Congress
  9. 2004 Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of all EGFR ligands Yale University School of Medicine davetli konuşmacı (Prof. Arthur Horwich tarafından davet edildi)
  10. 2018 PML Nuclear Bodies: From APL Cure to Therapeutic Perspectives Bilkent Üniversitesi Moleküler Biyoloji ve Genetik Bölümü Seminer Daveti
  11. 2015 PML Nuclear Bodies From Acute Promyelocytic Leukemia Cure to Novel Therapeutic Perspectives İzmir Biyotıp ve Genom Merkezi Seminer Daveti
  12. 2014 PML nuclear body enhanced sumoylation is druggable and can clear toxic protens 4th France-Japan Cancer Symposium
  13. 2004 Distinct roles for ADAM10 and ADAM17 in ectodomain cleavage of all EGFR ligands Stanford University davetli konuşmacı (Prof. Judith Frydman tarafından davet edildi)
  14. 2004 Distinct roles for ADAM10 and ADAM17 in ectodomain shedding and activation of all EGFR ligands California Institute of Technology davetli seminer (Prof. Ray Deshaies tarafından davet edildi)
  15. 2016 Cancer cure mediated by PML and SUMO proteins Türkiye Moleküler Biyoloji Derneği veri Toplantısı
  16. 2004 The role of ADAM17 in juxtacrine and autocrine EGFR signaling Genentech, Inc. davetli konuşmacı (Prof. Mark Sliwkowski tarafından davet edildi)
  17. 2016 PML Nuclear Bodies from APL cure to novel therapeutic perspectives İstanbul Teknik Üniversitesi
  18. 2019 Interferon clears ALS-linked toxic aggregates via PML nuclear bodies EMBO Young Investigator Meeting
  19. 2007 Essential role for ADAM10 and ADAM17 in ectodomain shedding of EGFR ligands Rockefeller University davetli konuşmacı (Prof. Sanford Simon tarafından davet edildi)
  20. 2016 PML nuclear bodies from APL cure to novel therapeutic perspectives Koç Üniversitesi

Back to academicians